🔎 Trials Near Me

Gara Jalqabaatti › Kansara Baadii Harkaa Non-Muscle Invasive › New York › New York City

Qorannoo klinikaalii Kansara Baadii Harkaa Non-Muscle Invasive New York City, NY keessatti

Qorannoo 10 Kansara Baadii Harkaa Non-Muscle Invasive f New York City fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer

Namoota walitti qabaa jiraSadarkaa 2
  • Icahn School of Medicine at Mount Sinai, New York
  • Weill Cornell Medical Center, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06503614

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

Namoota walitti qabaa jiraSadarkaa 3
  • Veterans Affairs New York Harbor Healthcare System-Manhattan Campus, New York
  • Memorial Sloan Kettering Cancer Center, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07000084

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

Namoota walitti qabaa jiraSadarkaa 2
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0111), New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06833073

Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer

Namoota walitti qabaa jiraSadarkaa 2
  • NYU Langone Health, New York
  • Memorial Sloan Kettering Cancer Center - Sidney Kimmel Center for Prostate and Urologic Cancers, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT06995677

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

Namoota walitti qabaa jiraSadarkaa 1
  • Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
  • Memorial Sloan Kettering Cancer Center 53rd street, New York
  • Icahn School of Medicine at Mount Sinai, New York
  • fi 3 dabalataa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07206225

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

Namoota walitti qabaa jiraSadarkaa 2
  • Laura & Isaac Perlmutter Cancer Center - NYU Langone Health, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Hag-2026 · NCT05951179

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

Namoota walitti qabaa jiraSadarkaa 1
  • New York University (NYU), New York
  • Weill Cornell Medicine, New York
  • Icahn School of Medicine at Mount Sinai, New York
  • fi 2 dabalataa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Hag-2026 · NCT05614739

A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)

Namoota walitti qabaa jiraSadarkaa 3
  • Columbia University (Data Collection Only), New York
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Umuriin 21 fi ol · Saalaa hunda · Haaromfame 20-Hag-2026 · NCT06929286

Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard Treatment

Namoota walitti qabaa jiraSadarkaa 1/2
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Hag-2026 · NCT05126472

Blue Light Cystoscopy With Cysview® Registry

Namoota walitti qabaa jiraQorannoo ilaalaa
  • NYU Langone's Perlmutter Cancer Center, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Mud-2025 · NCT02660645

Qorannoo Kansara Baadii Harkaa Non-Muscle Invasive magaalota biroo keessatti

Qorannoo biroo New York City keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.